|
Volumn 2, Issue 4, 2002, Pages 361-365
|
'Omic' and hypothesis-driven research in the molecular pharmacology of cancer
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
ARTICLE;
CANCER RESEARCH;
CONTROLLED STUDY;
DRUG RESEARCH;
GENE EXPRESSION;
GENOMICS;
HUMAN;
HYPOTHESIS;
METHODOLOGY;
MOLECULAR BIOLOGY;
NOMENCLATURE;
PHARMACOLOGICAL SCIENCE;
PRIORITY JOURNAL;
STATISTICAL ANALYSIS;
ANIMAL;
DRUG DESIGN;
NEOPLASM;
PHARMACEUTICS;
REVIEW;
ANIMALS;
DRUG DESIGN;
GENOMICS;
HUMANS;
MOLECULAR BIOLOGY;
NEOPLASMS;
TECHNOLOGY, PHARMACEUTICAL;
|
EID: 0036667384
PISSN: 14714892
EISSN: None
Source Type: Journal
DOI: 10.1016/S1471-4892(02)00185-6 Document Type: Note |
Times cited : (52)
|
References (18)
|